- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- monomer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.5: 3 residues within 4Å:- Chain A: S.19, N.43, V.57
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.19
NAG.6: 4 residues within 4Å:- Chain A: G.104, N.106, T.153, L.155
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:T.153
NAG.7: 2 residues within 4Å:- Chain A: G.162, N.164
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:G.162, A:N.164
NAG.8: 3 residues within 4Å:- Chain A: Q.338, L.339, N.340
No protein-ligand interaction detected (PLIP)NAG.9: 2 residues within 4Å:- Chain A: I.364, N.366
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:I.364
- Water bridges: A:N.366, A:N.366, A:N.366
- 31 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.10: 7 residues within 4Å:- Chain A: R.16, R.60, P.62, T.85, F.86, Q.87, R.146
Ligand excluded by PLIPEDO.11: 5 residues within 4Å:- Chain A: R.119, F.138, A.148, V.149
- Ligands: EDO.27
Ligand excluded by PLIPEDO.12: 4 residues within 4Å:- Chain A: R.230, V.231, V.244
- Ligands: EDO.40
Ligand excluded by PLIPEDO.13: 2 residues within 4Å:- Chain A: Q.78, R.80
Ligand excluded by PLIPEDO.14: 5 residues within 4Å:- Chain A: P.96, L.97, R.188, E.189
- Ligands: EDO.26
Ligand excluded by PLIPEDO.15: 4 residues within 4Å:- Chain A: R.174, G.177, L.178, G.179
Ligand excluded by PLIPEDO.16: 2 residues within 4Å:- Chain A: D.198, A.199
Ligand excluded by PLIPEDO.17: 1 residues within 4Å:- Chain A: V.11
Ligand excluded by PLIPEDO.18: 3 residues within 4Å:- Chain A: S.19, L.20, Q.55
Ligand excluded by PLIPEDO.19: 1 residues within 4Å:- Chain A: E.63
Ligand excluded by PLIPEDO.20: 5 residues within 4Å:- Chain A: R.84, A.120, S.121, H.176
- Ligands: EDO.35
Ligand excluded by PLIPEDO.21: 5 residues within 4Å:- Chain A: T.123, R.135, E.170, D.172, R.174
Ligand excluded by PLIPEDO.22: 1 residues within 4Å:- Chain A: R.60
Ligand excluded by PLIPEDO.23: 1 residues within 4Å:- Chain A: R.41
Ligand excluded by PLIPEDO.24: 3 residues within 4Å:- Chain A: A.293, K.365, R.367
Ligand excluded by PLIPEDO.25: 3 residues within 4Å:- Chain A: W.21, Q.46
- Ligands: NAG-NAG.1
Ligand excluded by PLIPEDO.26: 7 residues within 4Å:- Chain A: L.97, P.98, P.99, E.189, L.190, R.191
- Ligands: EDO.14
Ligand excluded by PLIPEDO.27: 6 residues within 4Å:- Chain A: V.113, P.114, G.147, A.148, V.149
- Ligands: EDO.11
Ligand excluded by PLIPEDO.28: 3 residues within 4Å:- Chain A: E.182, N.183, S.184
Ligand excluded by PLIPEDO.29: 4 residues within 4Å:- Chain A: R.201, T.219, L.220, D.221
Ligand excluded by PLIPEDO.30: 3 residues within 4Å:- Chain A: L.133, T.153, V.154
Ligand excluded by PLIPEDO.31: 4 residues within 4Å:- Chain A: S.349, S.368, A.369, E.370
Ligand excluded by PLIPEDO.32: 2 residues within 4Å:- Chain A: R.201, L.202
Ligand excluded by PLIPEDO.33: 3 residues within 4Å:- Chain A: A.315, G.316, P.334
Ligand excluded by PLIPEDO.34: 3 residues within 4Å:- Chain A: A.120, G.140, E.141
Ligand excluded by PLIPEDO.35: 3 residues within 4Å:- Chain A: R.84, H.176
- Ligands: EDO.20
Ligand excluded by PLIPEDO.36: 4 residues within 4Å:- Chain A: L.40, R.41, R.42
- Ligands: EDO.38
Ligand excluded by PLIPEDO.37: 3 residues within 4Å:- Chain A: R.47, G.48, W.51
Ligand excluded by PLIPEDO.38: 7 residues within 4Å:- Chain A: L.36, T.38, L.40, R.42, R.54, L.56
- Ligands: EDO.36
Ligand excluded by PLIPEDO.39: 2 residues within 4Å:- Chain A: E.264, S.290
Ligand excluded by PLIPEDO.40: 5 residues within 4Å:- Chain A: V.231, S.241, P.242, V.244
- Ligands: EDO.12
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Recacha, R. et al., Crystal structures of an ICAM-5 ectodomain fragment show electrostatic-based homophilic adhesions. Acta Crystallogr.,Sect.D (2014)
- Release Date
- 2014-07-16
- Peptides
- Intercellular adhesion molecule 5: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- monomer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 31 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Recacha, R. et al., Crystal structures of an ICAM-5 ectodomain fragment show electrostatic-based homophilic adhesions. Acta Crystallogr.,Sect.D (2014)
- Release Date
- 2014-07-16
- Peptides
- Intercellular adhesion molecule 5: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A